Prof. Seppo Ylä-Herttuala, Professor of Molecular Medicine at the University of Eastern Finland, National Director of EATRIS Finland, has been awarded the honorary title of Academician of Science, Finland’s highest scientific distinction.
The title was granted by President Alexander Stubb on 9 October 2026, following nominations by the Research Council of Finland. Reserved for a maximum of 16 scientists at any given time, the honour recognises exceptional contributions to scientific research.
An internationally recognised pioneer in molecular medicine and gene therapy, Prof. Ylä-Herttuala has advanced research into cardiovascular diseases and innovative gene transfer technologies.
His work has contributed to major clinical gene therapy trials in Europe and the United States, bridging fundamental discoveries and clinical applications.
Prof. Ylä-Herttuala has also contributed to establishing industrial-scale manufacturing capabilities for gene therapies, supporting the development of innovative treatments and strengthening Finland’s biotechnology sector.
Throughout his career spanning over 30 years, Prof. Ylä-Herttuala has supervised more than 100 doctoral researchers, contributed to over 20 patents and secured major international research funding, including several European Research Council Advanced Grants. As Director of the GeneCellNano Flagship, he continues to advance research in gene, cell and nanotherapies.
These achievements reflect the mission of EATRIS to accelerate the translation of scientific discoveries into innovative healthcare solutions. EATRIS congratulates Prof. Ylä-Herttuala on this distinguished recognition and celebrates his outstanding contributions to biomedical research and the advancement of innovative therapies.
